220 related articles for article (PubMed ID: 36611806)
21. BCL6 promotes glioma and serves as a therapeutic target.
Xu L; Chen Y; Dutra-Clarke M; Mayakonda A; Hazawa M; Savinoff SE; Doan N; Said JW; Yong WH; Watkins A; Yang H; Ding LW; Jiang YY; Tyner JW; Ching J; Kovalik JP; Madan V; Chan SL; Müschen M; Breunig JJ; Lin DC; Koeffler HP
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3981-3986. PubMed ID: 28356518
[TBL] [Abstract][Full Text] [Related]
22. The N
Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
Front Immunol; 2021; 12():653711. PubMed ID: 34354698
[TBL] [Abstract][Full Text] [Related]
23. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
Front Immunol; 2020; 11():1402. PubMed ID: 32765498
[TBL] [Abstract][Full Text] [Related]
24. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
[TBL] [Abstract][Full Text] [Related]
25. Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion.
Cao MF; Chen L; Dang WQ; Zhang XC; Zhang X; Shi Y; Yao XH; Li Q; Zhu J; Lin Y; Liu S; Chen Q; Cui YH; Zhang X; Bian XW
Cancer Lett; 2019 Feb; 442():445-452. PubMed ID: 30472185
[TBL] [Abstract][Full Text] [Related]
26. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Zhang J; Xiao X; Zhang X; Hua W
J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
[TBL] [Abstract][Full Text] [Related]
27. Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation.
Schmassmann P; Roux J; Dettling S; Hogan S; Shekarian T; Martins TA; Ritz MF; Herter S; Bacac M; Hutter G
Elife; 2023 Dec; 12():. PubMed ID: 38127790
[TBL] [Abstract][Full Text] [Related]
28. Analysis of immunobiologic markers in primary and recurrent glioblastoma.
Rahman M; Kresak J; Yang C; Huang J; Hiser W; Kubilis P; Mitchell D
J Neurooncol; 2018 Apr; 137(2):249-257. PubMed ID: 29302887
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L
Front Immunol; 2022; 13():964898. PubMed ID: 35967394
[TBL] [Abstract][Full Text] [Related]
30. Immune landscapes associated with different glioblastoma molecular subtypes.
Martinez-Lage M; Lynch TM; Bi Y; Cocito C; Way GP; Pal S; Haller J; Yan RE; Ziober A; Nguyen A; Kandpal M; O'Rourke DM; Greenfield JP; Greene CS; Davuluri RV; Dahmane N
Acta Neuropathol Commun; 2019 Nov; 7(1):203. PubMed ID: 31815646
[TBL] [Abstract][Full Text] [Related]
31. Quantification of glioblastoma progression in zebrafish xenografts: Adhesion to laminin alpha 5 promotes glioblastoma microtumor formation and inhibits cell invasion.
Gamble JT; Reed-Harris Y; Barton CL; La Du J; Tanguay R; Greenwood JA
Biochem Biophys Res Commun; 2018 Dec; 506(4):833-839. PubMed ID: 30389143
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
33. Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment.
Sisakht AK; Malekan M; Ghobadinezhad F; Firouzabadi SNM; Jafari A; Mirazimi SMA; Abadi B; Shafabakhsh R; Mirzaei H
Cell Mol Neurobiol; 2023 Mar; 43(2):585-603. PubMed ID: 35411434
[TBL] [Abstract][Full Text] [Related]
34. Local Targeting of NAD
Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
[TBL] [Abstract][Full Text] [Related]
35. Tumor Cell Microenvironment and Microvessel Density Analysis in MALT Type Lymphoma.
Tamma R; Ingravallo G; Annese T; DE Giorgis M; DI Giovanni F; Gaudio F; Perrone T; Musto P; Specchia G; Ribatti D
Anticancer Res; 2021 Mar; 41(3):1291-1297. PubMed ID: 33788720
[TBL] [Abstract][Full Text] [Related]
36. Three-dimensional vascular microenvironment landscape in human glioblastoma.
Cribaro GP; Saavedra-López E; Romarate L; Mitxitorena I; Díaz LR; Casanova PV; Roig-Martínez M; Gallego JM; Perez-Vallés A; Barcia C
Acta Neuropathol Commun; 2021 Feb; 9(1):24. PubMed ID: 33579378
[TBL] [Abstract][Full Text] [Related]
37. The Interplay between Glioblastoma and Its Microenvironment.
Dapash M; Hou D; Castro B; Lee-Chang C; Lesniak MS
Cells; 2021 Aug; 10(9):. PubMed ID: 34571905
[TBL] [Abstract][Full Text] [Related]
38. The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
Desland FA; Hormigo A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027976
[TBL] [Abstract][Full Text] [Related]
39. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
[TBL] [Abstract][Full Text] [Related]
40. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
